|
1
|
Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release.
|
AAPS PharmSci
|
2003
|
1.15
|
|
2
|
Immobilization of lipase using hydrophilic polymers in the form of hydrogel beads.
|
Biomaterials
|
2002
|
1.14
|
|
3
|
Studies on the interaction of water with ethylcellulose: effect of polymer particle size.
|
AAPS PharmSciTech
|
2003
|
1.13
|
|
4
|
Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables.
|
Pharm Dev Technol
|
2004
|
0.98
|
|
5
|
PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC.
|
Int J Pharm
|
2005
|
0.97
|
|
6
|
Effects of preparative parameters on the properties of chitosan hydrogel beads containing Candida rugosa lipase.
|
Biomaterials
|
2004
|
0.92
|
|
7
|
In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents.
|
Biomaterials
|
2002
|
0.87
|
|
8
|
The use of spray-drying to enhance celecoxib solubility.
|
Drug Dev Ind Pharm
|
2011
|
0.85
|
|
9
|
An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon.
|
Int J Pharm
|
2002
|
0.85
|
|
10
|
Molecular weight and degree of deacetylation effects on lipase-loaded chitosan bead characteristics.
|
Biomaterials
|
2002
|
0.84
|
|
11
|
Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats.
|
Int J Med Sci
|
2010
|
0.84
|
|
12
|
Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
|
Arch Pharm Res
|
2011
|
0.82
|
|
13
|
Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization.
|
Int J Pharm
|
2009
|
0.82
|
|
14
|
Colon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets.
|
Drug Dev Ind Pharm
|
2011
|
0.81
|
|
15
|
Extruded and spheronized beads containing Carbopol 974P to deliver nonelectrolytes and salts of weakly basic drugs.
|
Int J Pharm
|
2006
|
0.80
|
|
16
|
Crospovidone interactions with water. I. Calorimetric study of the effect of Polyplasdone particle size on its uptake and distribution of water.
|
J Pharm Sci
|
2014
|
0.79
|
|
17
|
Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized Carbopol-containing pellets.
|
Int J Pharm
|
2008
|
0.79
|
|
18
|
Water distribution studies within microcrystalline cellulose and chitosan using differential scanning calorimetry and dynamic vapor sorption analysis.
|
J Pharm Sci
|
2004
|
0.78
|
|
19
|
Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.
|
Int J Pharm
|
2012
|
0.77
|
|
20
|
Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product.
|
Arch Pharm Res
|
2010
|
0.77
|
|
21
|
Rheological and mucoadhesive characterization of poly(vinylpyrrolidone) hydrogels designed for nasal mucosal drug delivery.
|
Arch Pharm Res
|
2011
|
0.76
|
|
22
|
Coated hydralazine hydrochloride beads for sustained release after oral administration.
|
Drug Dev Ind Pharm
|
2012
|
0.75
|
|
23
|
Propranolol forms affect properties of Carbopol-containing extruded-spheronized beads.
|
Int J Pharm
|
2008
|
0.75
|
|
24
|
Technology evaluation: Kollicoat IR.
|
Expert Opin Drug Deliv
|
2011
|
0.75
|